Displaying 1 - 12 of 87
-
Frequently Asked Questions (FAQs): Product Transfer for the RTS,S/AS01 Malaria Vaccine
Published 27 Jan 2021Fact sheet -
Characterization of two in vivo challenge models to measure functional activity of monoclonal antibodies to Plasmodium falciparum circumsporozoite protein
Published 17 Mar 2020Journal article -
RTS,S Malaria Vaccine: 2019 Partnership Award Honoree
Published 4 Dec 2019Video -
The RTS,S malaria vaccine
Published 17 Sep 2019Fact sheet -
RTS,S malaria vaccine frequently asked questions (FAQs)
Published 17 Sep 2019Fact sheet -
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
Published 15 Aug 2019Journal article -
Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomized controlled trial
Published 9 Jul 2019Journal article -
RTS,S malaria vaccine implementation in Ghana
Published 14 May 2019Fact sheet -
RTS,S malaria vaccine implementation in Malawi
Published 13 May 2019Fact sheet -
Bridging the gaps in malaria R&D: An analysis of funding—from basic research and product development to research for implementation
Published 19 Jun 2018Report -
Working to beat malaria: the Malaria Vaccine Implementation Programme
Published 25 Apr 2018Video -
PATH's Malaria Vaccine Initiative
Published 13 Apr 2018Fact sheet